Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (R)-adrenaline | multiple interactions | ISO | Gng4 (Mus musculus) | 6480464 | Epinephrine promotes the reaction [GNG4 protein binds to ADRA2A protein] | CTD | PMID:30737458 | 17beta-estradiol | multiple interactions | ISO | GNG4 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of GNG4 mRNA | CTD | PMID:20660070 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Gng4 (Mus musculus) | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of GNG4 mRNA] | CTD | PMID:16891777 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GNG4 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Gng4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GNG4 mRNA | CTD | PMID:16891777 and PMID:33956508 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of GNG4 mRNA | CTD | PMID:21346803 | 4,4'-sulfonyldiphenol | decreases expression | ISO | Gng4 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of GNG4 mRNA | CTD | PMID:34850234 | aflatoxin B1 | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of GNG4 mRNA | CTD | PMID:21641981 | all-trans-retinoic acid | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of GNG4 mRNA | CTD | PMID:15498508 more ... | all-trans-retinoic acid | multiple interactions | ISO | Gng4 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GNG4 mRNA | CTD | PMID:36189433 | antirheumatic drug | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of GNG4 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of GNG4 mRNA | CTD | PMID:33212167 | arsenite(3-) | increases expression | ISO | Gng4 (Mus musculus) | 6480464 | arsenite results in increased expression of GNG4 mRNA | CTD | PMID:33053406 | arsenite(3-) | increases methylation | ISO | GNG4 (Homo sapiens) | 6480464 | arsenite results in increased methylation of GNG4 promoter | CTD | PMID:23974009 | atrazine | increases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Atrazine results in increased expression of GNG4 mRNA | CTD | PMID:22378314 | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of GNG4 gene | CTD | PMID:35440735 | benzo[a]pyrene | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of GNG4 mRNA | CTD | PMID:21632981 and PMID:26238291 | benzo[a]pyrene | affects methylation | ISO | GNG4 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of GNG4 5' UTR more ... | CTD | PMID:27901495 and PMID:30157460 | benzo[a]pyrene | increases methylation | ISO | GNG4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of GNG4 exon | CTD | PMID:27901495 | benzo[e]pyrene | increases methylation | ISO | GNG4 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of GNG4 intron | CTD | PMID:30157460 | bisphenol A | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of GNG4 mRNA | CTD | PMID:25912373 | bisphenol A | decreases expression | ISO | Gng4 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of GNG4 mRNA | CTD | PMID:32156529 and PMID:34850234 | bisphenol A | decreases methylation | ISO | GNG4 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of GNG4 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GNG4 mRNA | CTD | PMID:30816183 and PMID:34947998 | bisphenol A | increases methylation | ISO | GNG4 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of GNG4 promoter | CTD | PMID:27271280 | butanal | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of GNG4 mRNA | CTD | PMID:26079696 | carbamazepine | affects expression | ISO | GNG4 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of GNG4 mRNA | CTD | PMID:24752500 | copper(II) sulfate | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of GNG4 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of GNG4 mRNA | CTD | PMID:25562108 | dextran sulfate | multiple interactions | ISO | Gng4 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNG4 mRNA | CTD | PMID:29950665 | diclofenac | affects expression | ISO | GNG4 (Homo sapiens) | 6480464 | Diclofenac affects the expression of GNG4 mRNA | CTD | PMID:24752500 | dorsomorphin | multiple interactions | ISO | GNG4 (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | ethanol | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Ethanol results in decreased expression of GNG4 mRNA | CTD | PMID:23378141 | ethanol | multiple interactions | ISO | GNG4 (Homo sapiens) | 6480464 | [Ethanol co-treated with Folic Acid] results in decreased expression of GNG4 mRNA | CTD | PMID:23378141 | ethyl methanesulfonate | increases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of GNG4 mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | ISO | GNG4 (Homo sapiens) | 6480464 | [Ethanol co-treated with Folic Acid] results in decreased expression of GNG4 mRNA | CTD | PMID:23378141 | folic acid | decreases expression | ISO | Gng4 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of GNG4 mRNA | CTD | PMID:25629700 | formaldehyde | increases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of GNG4 mRNA | CTD | PMID:23649840 | isotretinoin | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Isotretinoin results in decreased expression of GNG4 mRNA | CTD | PMID:20436886 | L-ascorbic acid | increases expression | ISO | Gng4 (Mus musculus) | 6480464 | Ascorbic Acid results in increased expression of GNG4 mRNA | CTD | PMID:15305145 | lead(0) | affects expression | ISO | GNG4 (Homo sapiens) | 6480464 | Lead affects the expression of GNG4 mRNA | CTD | PMID:28903495 | lipopolysaccharide | multiple interactions | ISO | GNG4 (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of GNG4 mRNA] | CTD | PMID:35811015 | lipopolysaccharide | increases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of GNG4 mRNA | CTD | PMID:35811015 | methapyrilene | increases methylation | ISO | GNG4 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of GNG4 intron | CTD | PMID:30157460 | methyl methanesulfonate | increases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of GNG4 mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | ISO | GNG4 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of GNG4 mRNA | CTD | PMID:23179753 more ... | methylmercury chloride | multiple interactions | ISO | GNG4 (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNG4 mRNA | CTD | PMID:27188386 | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Gng4 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GNG4 mRNA | CTD | PMID:36189433 | paracetamol | affects expression | ISO | Gng4 (Mus musculus) | 6480464 | Acetaminophen affects the expression of GNG4 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of GNG4 mRNA | CTD | PMID:30723492 | phenobarbital | affects expression | ISO | Gng4 (Mus musculus) | 6480464 | Phenobarbital affects the expression of GNG4 mRNA | CTD | PMID:19136022 | phenylmercury acetate | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of GNG4 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | GNG4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GNG4 mRNA | CTD | PMID:27188386 | pirinixic acid | affects expression | ISO | Gng4 (Mus musculus) | 6480464 | pirinixic acid affects the expression of GNG4 mRNA | CTD | PMID:19136022 | pirinixic acid | decreases expression | ISO | Gng4 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of GNG4 mRNA | CTD | PMID:17950772 | progesterone | multiple interactions | ISO | GNG4 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of GNG4 mRNA | CTD | PMID:20660070 | quercetin | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of GNG4 mRNA | CTD | PMID:21632981 | resveratrol | multiple interactions | ISO | GNG4 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of GNG4 mRNA | CTD | PMID:23557933 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | GNG4 (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of GNG4 mRNA] | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | GNG4 (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of GNG4 mRNA | CTD | PMID:23806026 | silicon dioxide | increases expression | ISO | Gng4 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of GNG4 mRNA | CTD | PMID:29203145 | sodium arsenite | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of GNG4 mRNA | CTD | PMID:34032870 | succimer | multiple interactions | ISO | Gng4 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GNG4 mRNA | CTD | PMID:21641980 | tamibarotene | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | tamibarotene results in decreased expression of GNG4 mRNA | CTD | PMID:15498508 | testosterone | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of GNG4 mRNA | CTD | PMID:33359661 | thimerosal | increases expression | ISO | Gng4 (Mus musculus) | 6480464 | Thimerosal results in increased expression of GNG4 mRNA | CTD | PMID:24675092 | titanium dioxide | multiple interactions | ISO | Gng4 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNG4 mRNA | CTD | PMID:29950665 | titanium dioxide | decreases methylation | ISO | GNG4 (Homo sapiens) | 6480464 | titanium dioxide results in decreased methylation of GNG4 gene | CTD | PMID:34973136 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of GNG4 mRNA | CTD | PMID:33387578 | tunicamycin | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of GNG4 mRNA | CTD | PMID:22378314 | urethane | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Urethane results in decreased expression of GNG4 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | GNG4 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of GNG4 mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | ISO | GNG4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNG4 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of GNG4 mRNA | CTD | PMID:23179753 more ... | vitamin E | decreases expression | ISO | GNG4 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of GNG4 mRNA | CTD | PMID:19244175 | |